Calvopina M, Chávez-Rios G, Khan A, Diaz-Najul CE

Language: Spanish
References: 10
Page: 1-9
PDF size: 326.22 Kb.

ABSTRACT

Introduction: Pulmonary paragonimiasis is an uncommon tropical trematode infection caused by Paragonimus spp. Acquired through the intake of freshwater crabs, this condition is characterized by respiratory symptoms such as chronic coughing and rusty expectoration. Pleural effusion is a rare complication accompanied by dyspnea and difficulty breathing.
Objective: Describe a case of bilateral pleural effusion due to Paragonimus spp. infection.
Clinical case: A female 51-year-old indigenous Kichwa woman was admitted for difficulty breathing and progressive dyspnea, coughing and hemoptoic expectoration. Chest radiography and computed axial tomography showed bilateral pleural effusion, whereas Paragonimus spp. eggs were visible in sputum samples under the microscope. Praziquantel 1 800 mg/day was administered for three days. The patient was discharged on the fifth day and at 45 days the respiratory picture and the pleural effusion were found to have resolved.
Conclusions: Consideration should be given to the search for eggs of the parasite in sputum and/or pleural fluid of patients with respiratory symptoms and pleural effusion, even if they are migrants from endemic countries, with a view to an early diagnosis and timely treatment.

REFERENCES

1. Acha P, Szyfres B. Zoonosis y enfermedades transmisibles comunes al hombre y a los animales. Parasitosis. Vol. III, 3rd ed., Washington DC: PAHO; 2003. p. 158-64.

2. Calvopiña M, Romero D, Castañeda B, Hashiguchi Y, Sugiyama H. Current Status of Paragonimus and paragonimiasis in Ecuador. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2015;109:849-55. Doi: https://doi.org/10.1590/0074-0276140042

3. Centers for Disease Contro and Prevention, CDC. Parasites. Paragonimus. [acceso: 01/10/2020]. Disponible en: Disponible en: https://www.cdc.gov/parasites/paragonimus/

4. Calvopiña M, Romero-Alvarez D, Macias R, Sugiyama H. Severe Pleuropulmonary Paragonimiasis Caused by Paragonimus mexicanus Treated as Tuberculosis in Ecuador. Am J Trop Med Hyg. 2017;96:97-9. Doi: https://doi.org/10.4269/ajtmh.16-0351

5. Peñafiel W, Dávalos R, Coloma M. Paragonimiasis pulmonar. Revisión clínica de 92 casos. Rev Fac Ciencias Méd. 1981;6:253-61.

6. Calvopiña M, Guderian R, Paredes W, Cooper PJ. Comparison of two single-day regimens of triclabendazole for the treatment of human pulmonary paragonimiasis. Trans Roy Soc Trop Med Hyg. 2003;97:451-4.

7. Im JG, Whang HY, Kim WS, Han MC, Shim YS, Cho SY. Pleuropulmonary paragonimiasis: radiologic findings in 71 patients. Am J Roentgenol. 1992;159:39-43.

8. Gómez-Seco J, Rodríguez-Guzmán MJ, Rodríguez-Nieto MJ, Gómez-Escolar PF, Presa-Abos T, Fortes-Alen J. Paragonimiasis pulmonar. Arch Bronconeumol. 2011;47:610-2.

9. Villacís S, Mena S, Acosta J, Mora-Brito E, Leiva L, Carrero Y. Dificultad en el diagnóstico de Paragonimiasis en centros de primer nivel. Reporte de un caso. Kasmera. 2020;48(1):e48117072019. Doi: https://doi.org/10.5281/zenodo.3593890

10. Ministerio de Salud Pública del Ecuador. Consejo Nacional de Salud. Comisión Nacional de Medicamentos e Insumos. Cuadro Nacional de Medicamentos Básicos 2019. CNMB 2019. 10ma revisión. [acceso: 01/10/20]. Disponible en: Disponible en: http://www.conasa.gob.ec/biblioteca/Xcnmb/Cuadro_Nacional_de_Medicamentos_Basicos.pdf